Airway Inflammation Clinical Trial
Official title:
Phase I/II Randomized, Double-blind, Placebo-controlled Cross-over Study of Prednisone on Airway Inflammatory Response to Inhaled Wood Smoke
Deployment of military personnel has been associated with increased respiratory illness likely due, in part, to inhalation of unusual particulate matter (PM), such as from burn pits. Inflammation is a key initial response to inhaled particulates. The researchers have developed a protocol using inhaled wood smoke particles (WSP) as a way to study PM-induced airway inflammation. Exposure to wood smoke particles causes symptoms, even in healthy people, such as eye irritation, cough, shortness of breath, and increased mucous production. The purpose of this research study is to see if an oral steroid treatment can reduce the airway inflammation caused by the inhaled WSP. The exposure will be 500 µg/m³ of WSP for 2 hours, with intermittent exercise on a bicycle and rest. The wood is burned in a typical wood stove and piped into the chamber.
Military deployment is associated with exposure to novel particulate matter (PM), such as from burn pits, aeroallergens, and increased cigarette consumption. War fighters exposed to these inhalational exposures exhibit immediate and chronic respiratory morbidity. For example, military service personnel surveyed in both the Republic of Korea (ROK) and Kabul, Afghanistan reported a general increase in respiratory morbidity, including asthma and chronic bronchitis, associated with their deployment. Air contaminants in the ROK were characterized by elevated levels of both PM 0.5-2.5 and PM 2.5-10. Similarly, exposures in Kabul were characterized by multiple airborne PM exposures, including those from burn pits. Burn pit PM includes metals, bioaerosols, organic by-products, and biomass combustion particles. These findings indicate that inhaled PM is a likely cause of respiratory morbidity in the field. Inflammation is a key initial response to inhaled particulates. Wood smoke particles (WSP) serve as a model agent to study PM-induced bronchitis. WSP inhalation generates reactive oxidant (and nitrosative) species which cause local injury of airway epithelial cells and release of damage-associated molecular patterns (DAMPs) that activate toll-like receptors (TLR) and Interleukin (IL)-1-mediated innate immune responses by resident airway macrophages. Contamination of PM with bioaerosols, which contain lipopolysaccharide (LPS), also activates innate immune responses through toll-like receptor 4 (TLR4) activation of resident airway macrophages. These complementary processes result in recruitment of neutrophils (PMN), which mediate luminal airway inflammation with release of toxic mediators such as neutrophil elastase and myeloperoxidase that promote acute and chronic bronchitis. Therefore, mitigation of PM-induced airway neutrophilic inflammation should be a key focus in order to reduce the respiratory morbidity of military personnel. The researchers have studied a number of pro-inflammatory inhaled agents, such as nebulized LPS, ozone (O3), and WSP, as models of acute neutrophilic bronchitis against which to test a number of therapeutic agents. To this effect, the researchers have reported that inhaled fluticasone inhibits O3-induced and LPS-induced neutrophilic inflammation, and that parenteral anakinra and oral gamma-tocopherol inhibit neutrophilic responses to inhaled LPS. In this study, the researchers will evaluate the efficacy of oral prednisone, a readily available anti-inflammatory medication commonly used in airway inflammatory diseases, in mitigating WSP-induced airway inflammation. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00994175 -
A Randomized, Placebo-Controlled, Double-Blind Pilot Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma
|
Phase 2 | |
Not yet recruiting |
NCT04885738 -
The Value of FeNO in Predicting Airway Eosinophilic Inflammation
|
||
Recruiting |
NCT02767973 -
To Identify Persons Who Are Susceptible to WSP-induced Inflammation and Examine the Role of GSTM1 and Other Factors in This Susceptibility
|
N/A | |
Completed |
NCT00814281 -
Airborne Ultrafine and Fine Particulate Matter: A Cause for Endothelial Dysfunction in Man?
|
N/A | |
Completed |
NCT00869596 -
Study of Biomarkers of Airway Inflammation (0000-128)
|
Phase 1 | |
Completed |
NCT00455377 -
Lung Function and Airway Inflammation in Portland Cement Workers
|
N/A | |
Completed |
NCT00527345 -
Children's Exposures/Health Effects/Diesel Exhaust
|
N/A | |
Completed |
NCT03444298 -
A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults
|
Phase 2 | |
Withdrawn |
NCT00604578 -
Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma
|
Phase 2 | |
Completed |
NCT00989365 -
Effect of Aerobic Training on Asthmatic Patients
|
N/A | |
Completed |
NCT00673907 -
HIPWOODS - Health Effects Related to Exposure to Particle Pollution From Woodburning Stoves
|
N/A | |
Completed |
NCT00635882 -
Asthma Study Comparing Anti-Inflammatory Effects of 3 Doses of Mometasone Furoate/Formoterol Fumarate and Medium Dose Mometasone Furoate (Study P05122 AM1)(COMPLETED)
|
Phase 2 | |
Enrolling by invitation |
NCT03851406 -
Woodsmoke Particulate + Hypertonic Saline
|
N/A | |
Completed |
NCT03924635 -
An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients
|
Phase 4 | |
Completed |
NCT00727714 -
Lung Function and Inflammatory Markers in Cement Dust Exposed Workers: A Cross-shifts Study
|
N/A |